Conversations Are the Source of Truth in Healthcare with Abridge CEO Shiv Rao

In this episode of No Priors, Elad and Sarah chat with Shiv Rao, MD, founder and CEO of Abridge. They dive into how Abridge is reshaping healthcare by creating AI tools that enhance clinical documentation and improve doctor-patient interactions. Shiv shares his thoughts on building trust with established healthcare systems, giving agency and time back to clinicians, and what makes the healthcare AI opportunity different today. They also discuss Abridge’s approach to developing and launching AI products, along with Shiv’s journey in founding Abridge. Sign up for new podcasts every week. Email feedback to show@no-priors.com Follow us on Twitter: @NoPriorsPod | @Saranormous | @EladGil | @ShivdevRao Show Notes:  0:00 Introduction  0:35 Abridge’s Story and Vision  5:30 Strategy for Customer Choice  7:41 Healthcare AI Opportunities  11:24 Navigating Incumbent Partnerships  14:26 Doctor-Centric AI Solutions  19:54 Abridge’s Future Plans  22:13 AI’s Impact on Healthcare  28:43 Shipping and Iterating Products  32:50 Shiv’s Journey to Abridge

Om Podcasten

At this moment of inflection in technology, co-hosts Elad Gil and Sarah Guo talk to the world's leading AI engineers, researchers and founders about the biggest questions: How far away is AGI? What markets are at risk for disruption? How will commerce, culture, and society change? What’s happening in state-of-the-art in research? “No Priors” is your guide to the AI revolution. Email feedback to show@no-priors.com. Sarah Guo is a startup investor and the founder of Conviction, an investment firm purpose-built to serve intelligent software, or "Software 3.0" companies. She spent nearly a decade incubating and investing at venture firm Greylock Partners. Elad Gil is a serial entrepreneur and a startup investor. He was co-founder of Color Health, Mixer Labs (which was acquired by Twitter). He has invested in over 40 companies now worth $1B or more each, and is also author of the High Growth Handbook.